(Reuters) - CHICAGO, June 3 - GlaxoSmithKline's new breast
cancer pill Tykerb might help prevent the growth of tumors in
some people with a hard-to-treat form of the disease, U.S.
researchers reported on Sunday.
The addition of Tykerb to standard chemotherapy treatment
failed to help most breast cancer patients, the researchers
told a meeting of the American Society of Clinical Oncology.
Read more at Reuters.com Government Filings News
cancer pill Tykerb might help prevent the growth of tumors in
some people with a hard-to-treat form of the disease, U.S.
researchers reported on Sunday.
The addition of Tykerb to standard chemotherapy treatment
failed to help most breast cancer patients, the researchers
told a meeting of the American Society of Clinical Oncology.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment